Joshua R. Disbrow

2023 - AYTU BIOPHARMA

In 2023, Joshua R. Disbrow earned a total compensation of $708K as Chairman and Chief Executive Officer since December at AYTU BIOPHARMA, a 20% increase compared to previous year.

Compensation breakdown

Bonus$118,000
Salary$590,000
Total$708,000

Disbrow received $590K in salary, accounting for 83% of the total pay in 2023.

Disbrow also received $118K in bonus.

Rankings

In 2023, Joshua R. Disbrow's compensation ranked 1,542nd out of 2,785 executives tracked by ExecPay. In other words, Disbrow earned more than 44.6% of executives.

ClassificationRankingPercentile
All
1,542
out of 2,785
45th
Division
Manufacturing
910
out of 1,525
40th
Major group
Chemicals And Allied Products
584
out of 864
32nd
Industry group
Drugs
568
out of 827
31st
Industry
Pharmaceutical Preparations
399
out of 592
33rd
Source: SEC filing on May 10, 2024.

Disbrow's colleagues

We found two more compensation records of executives who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2023.

2023

Greg Pyszczymuka

AYTU BIOPHARMA

Chief Commercial Officer since January

2023

Mark Oki

AYTU BIOPHARMA

Chief Financial Officer

News

You may also like